FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 67 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,684 | +32.1% | 61,190 | -1.8% | 0.00% | – |
| Q2 2023 | $205,663 | -66.0% | 62,322 | -70.6% | 0.00% | – |
| Q1 2023 | $604,773 | -58.0% | 212,201 | +7.3% | 0.00% | – |
| Q4 2022 | $1,440,392 | +34.5% | 197,856 | +49.4% | 0.00% | – |
| Q3 2022 | $1,071,000 | +109.2% | 132,473 | +26.9% | 0.00% | – |
| Q2 2022 | $512,000 | -78.5% | 104,420 | +3.8% | 0.00% | – |
| Q1 2022 | $2,380,000 | +33.6% | 100,639 | -0.0% | 0.00% | – |
| Q4 2021 | $1,781,000 | -33.5% | 100,670 | +5.9% | 0.00% | -100.0% |
| Q3 2021 | $2,680,000 | +300.0% | 95,031 | +48.6% | 0.00% | – |
| Q2 2021 | $670,000 | +34.8% | 63,972 | +51.4% | 0.00% | – |
| Q1 2021 | $497,000 | -1.4% | 42,247 | -1.8% | 0.00% | – |
| Q4 2020 | $504,000 | +73.2% | 43,012 | +17.7% | 0.00% | – |
| Q3 2020 | $291,000 | -50.1% | 36,555 | +14.5% | 0.00% | – |
| Q2 2020 | $583,000 | +46.5% | 31,914 | -4.2% | 0.00% | – |
| Q1 2020 | $398,000 | – | 33,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |